364 related articles for article (PubMed ID: 16955991)
1. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
[TBL] [Abstract][Full Text] [Related]
2. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
[TBL] [Abstract][Full Text] [Related]
3. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
[TBL] [Abstract][Full Text] [Related]
4. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
Vermeiden M; van den Broek WW; Mulder PG; Birkenhäger TK
J Psychopharmacol; 2010 Apr; 24(4):497-502. PubMed ID: 19423613
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.
Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
Am J Psychiatry; 2004 Nov; 161(11):2060-5. PubMed ID: 15514407
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants.
Heijnen WT; van den Broek WW; Mulder PG; Birkenhäger TK
J Psychopharmacol; 2010 Apr; 24(4):559-63. PubMed ID: 19028834
[TBL] [Abstract][Full Text] [Related]
7. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
Miljković BR; Pokrajac M; Timotijević I; Varagić V
Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
[TBL] [Abstract][Full Text] [Related]
8. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition.
Bruijn JA; Moleman P; Mulder PG; van den Broek WW
J Clin Psychiatry; 1998 Dec; 59(12):657-63. PubMed ID: 9921699
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
[TBL] [Abstract][Full Text] [Related]
11. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735
[TBL] [Abstract][Full Text] [Related]
12. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study.
Shahal B; Piel E; Mecz L; Kremer I; Klein E
Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923
[No Abstract] [Full Text] [Related]
13. Treatment of major affective disorder with fluvoxamine.
Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
[TBL] [Abstract][Full Text] [Related]
14. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
[TBL] [Abstract][Full Text] [Related]
15. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.
Laird LK; Lydiard RB; Morton WA; Steele TE; Kellner C; Thompson NM; Ballenger JC
J Clin Psychiatry; 1993 Jun; 54(6):224-8. PubMed ID: 8331091
[TBL] [Abstract][Full Text] [Related]
17. [Addition of lithium to medication in depressive patient resistant to treatment with tricyclic antidepressive agents].
Naarding P; van den Broek WW; Bruijn JA; Moleman P
Ned Tijdschr Geneeskd; 1995 Mar; 139(11):574-7. PubMed ID: 7700394
[TBL] [Abstract][Full Text] [Related]
18. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
[No Abstract] [Full Text] [Related]
19. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.
Schöpf J; Baumann P; Lemarchand T; Rey M
Pharmacopsychiatry; 1989 Sep; 22(5):183-7. PubMed ID: 2682692
[TBL] [Abstract][Full Text] [Related]
20. Fluvoxamine in the treatment of depressive illness. A series of double-blind hospital based comparative studies carried out in the UK.
Whitehead AM; Ashford JJ
Br J Clin Pract; 1992; 46(1):21-3. PubMed ID: 1419548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
